Pneumococcal conjugate vaccines (PCVs)
          Routine vaccination:
  - Minimum age: 6 weeks
  - Both PCV10 and PCV13 are licensed for children from 6 weeks to 5 years of age.

  - Additionally, PCV13 is licensed for the prevention of pneumococcal diseases in adults > 50

    years of age.
  - Primary schedule (for both PCV10 and PCV13): 3 primary doses at 6, 10, and 14 weeks with

    a booster at age 12 through 15 months.
Catch-up vaccination:
  - Administer 1 dose of PCV13 or PCV10 to all healthy children aged 24 through 59 months who      are not completely vaccinated for their age.
  - For PCV 13: Catch-up in 6–12 months: 2 doses 4 weeks apart and 1 booster;

                                       12–23 months: 2 doses 8 weeks apart;

                                       24 months and above: Single dose
  - For PCV10: Catch up in 6–12 months: 2 doses 4 weeks apart and 1 booster;

                                      12 months to 5 years: 2 doses 8 weeks apart
  - Vaccination of persons with high-risk conditions: PCV and pneumococcal polysaccharide

     vaccine [PPSV] both are used in certain high-risk group of children.
  - For children aged 24 through 71 months with certain underlying medical conditions,

     administer 1 dose of PCV13 if 3 doses of PCV were received previously, or

     administer 2 doses of PCV13 at least 8 weeks apart if fewer than 3 doses
     of PCV were received previously.
  - A single dose of PCV13 may be administered to previously unvaccinated children aged 6 

    through 18 years who have
         - anatomic or functional asplenia (including sickle cell disease),
         - HIV infection or an immunocompromising condition,

         - cochlear implant or cerebrospinal fluid leak.
  - Administer PPSV23 at least 8 weeks after the last dose of PCV to children aged 2 years or

     older with certain underlying medical conditions.